The physiology of a local renin–angiotensin system in the pancreas
Open Access
- 21 March 2007
- journal article
- review article
- Published by Wiley in The Journal of Physiology
- Vol. 580 (1) , 31-37
- https://doi.org/10.1113/jphysiol.2006.126193
Abstract
The systemic renin–angiotensin system (RAS) plays an important role in regulating blood pressure, electrolyte and fluid homeostasis. However, local RASs also exist in diverse tissues and organs, where they play a multitude of autocrine, paracrine and intracrine physiological roles. The existence of a local RAS is now recognized in pancreatic acinar, islet, duct, endothelial and stellate cells, the expression of which is modulated in response to physiological and pathophysiological stimuli such as hypoxia, pancreatitis, islet transplantation, hyperglycaemia, and diabetes mellitus. This pancreatic RAS has been proposed to have important endocrine and exocrine roles in the pancreas, regulating local blood flow, duct cell sodium bicarbonate secretion, acinar cell digestive enzyme secretion, islet beta‐cell (pro)insulin biosynthesis, and thus, glucose‐stimulated insulin release, delta‐cell somatostatin secretion, and pancreatic cell proliferation and differentiation. It may further mediate oxidative stress‐induced cell inflammation, apoptosis and fibrosis. Further exploration of this system would probably offer new insights into the pathogenesis of pancreatitis, diabetes, cystic fibrosis and pancreatic cancer formation. New therapeutic targets and strategies might thus be suggested.Keywords
This publication has 51 references indexed in Scilit:
- Angiotensin II Type 1 Receptor Antagonism Mediates Uncoupling Protein 2-Driven Oxidative Stress and Ameliorates Pancreatic Islet β-Cell Function in Young Type 2 Diabetic MiceAntioxidants and Redox Signaling, 2007
- Physiology of Local Renin-Angiotensin SystemsPhysiological Reviews, 2006
- Pancreatic islet blood flow is selectively enhanced by captopril, irbesartan and pravastatin, and suppressed by palmitateBiochemical and Biophysical Research Communications, 2006
- Beneficial effects of candesartan, an angiotensin II type 1 receptor blocker, on β-cell function and morphology in db/db miceBiochemical and Biophysical Research Communications, 2006
- Increased expression of NAD(P)H oxidase in islets of animal models of Type 2 diabetes and its improvement by an AT1 receptor antagonistBiochemical and Biophysical Research Communications, 2005
- Ramipril treatment suppresses islet fibrosis in Otsuka Long–Evans Tokushima fatty ratsBiochemical and Biophysical Research Communications, 2004
- Renin–angiotensin systems: the new frontierThe International Journal of Biochemistry & Cell Biology, 2003
- Characterization of a functional AT1A angiotensin receptor in pancreatoma AR4–2J cells☆Peptides, 1999
- Characterization of angiotensin II receptor subtypes in pancreatic acinar AR42J cellsPeptides, 1995
- Pharmacological characterization of angiotensin II binding sites in the canine pancreasPeptides, 1992